silyl ethers formed during this conversion and then metha-
nolic base to convert any C(R) axial diastereomer to the more
stable equatorial form 11. The hydroxyl group of 11 was
protected as the phenylcarbamate, and the acetonide unit was
transformed in the usual way to the epoxide subunit of 13.
Finally, MeAlCl2-catalyzed tricyclization of 13 followed by
deprotection and silica gel chromatography gave levorotatory
serratenediol corresponding to the natural product by com-
Scheme 1a
1
parison of H and 13C NMR spectra, infrared spectrum,
optical rotation, and melting point.1,2,9
The success of the short and simple synthesis of the
complex serratenediol structure 1 by the pathway shown in
Scheme 1 depended on several crucial steps, including the
application of catalyst 4 to the construction of chiral glycol
5, the stereoselective coupling of 8 and 9 to form 10, and
the cationic cyclizations used to generate 11 and 14. The
power of these epoxide-initiated, stereoselective cationic
cyclizations, nonenzymic mimics of biosynthetic processes,
is clearly demonstrated here, as it has been in other recent
syntheses.10
a (a) (MeO)2 CMe2, cat. p-TsOH, 0.5 h, 23 °C. (b) K2CO3,
MeOH, 1 h, 23 °C. (c) CH3SO2Cl, Et3N, CH2Cl2, 1 h, -42 °C,
then 0.5 h, 0 °C; then LiBr, THF, 1 h, 0 °C (91% of 6 from 5). (d)
2 equiv of LDA, 2 equiv of EtOAc, 4 equiv of CuI, THF at -110
°C, then -110 to -30 °C and 1 h at -30 °C (92% of 7 from 6).
(e) LiAlH4, Et2O, 1 h at 23 °C, then 0.5 h at 40 °C. (f) Ph3P,
imidazole, I2, CH2Cl2, 0.5 h, 23 °C. (g) 2 equiv of PhSO2Na, DMF,
24 h, 23 °C (78% of 8 from 7). (h) 8 + BuLi in 1:1 THF/Et2O for
0.5 h at -78 °C, then 9 for 0.5 h at 0 °C (89% of 10). (i) 1.2 equiv
of MeAlCl2, CH2Cl2, 0.3 h at -94 °C. (j) Bu4NF, THF then 10%
KOH in CH3OH for 3 h at reflux (75% of 11 from 10). (k) PhNCO,
py, 12 h at 23 °C. (l) CH3PPh3Br, KOtBu, C6H6, 2 h at 80 °C
(68% of 12 from 11). (m) 3:1 HOAc/H2O, 5 h at 50 °C. (n)
CH3SO2Cl, py, 12 h at 23 °C. (o) K2CO3/MeOH, 5 h at 23 °C
(80% of 13 from 12). (p) 1.3 equiv of MeAlCl2, CH2Cl2, 1 h at
-78 °C. (q) 40% KOH, MeOH, 1.5 h at 100 °C, then silica gel
chromatography (21% of 1 from 13).
Acknowledgment. This research was supported by a
Canadian NSERC fellowship and by Pfizer Inc.
Supporting Information Available: Full experimental
procedures for the synthesis of 1 from geranyl and farnesyl
acetate. This material is available free of charge via the
OL016543A
(9) Fang, J.-M.; Tsai, W.-Y.; Cheng, Y.-S. Phytochemistry 1991, 30,
1333.
(10) See, for example: (a) Huang, A. X.; Xiong, Z.; Corey, E. J. J. Am.
Chem. Soc. 1999, 121, 9999. (b) Corey, E. J.; Lin, S. J. Am. Chem. Soc.
1996, 118, 8765. (c) Corey, E. J.; Luo, G.; Lin, S. J. Am. Chem. Soc. 1997,
119, 9927. (d) Corey, E. J.; Lee, J. J. Am. Chem. Soc. 1993, 115, 8873. (e)
Corey, E. J.; Lee, J.; Liu, D. R. Tetrahedron Lett. 1994, 35, 9149.
10, in a second key step in the synthesis of 1. Conversion of
10 to the bicyclic hydroxy ketone 11 was effected by
MeAlCl2-catalyzed, epoxide-initiated cationic cyclization
followed by treatment of the product with Bu4NF to cleave
3216
Org. Lett., Vol. 3, No. 20, 2001